[Synergistic effects of immunomodulators of the muramyl peptide type and other drugs used together with chemotherapy].
Dzierzbicka
K
K
Katedra Chemii Organicznej, Politechnika Gdańska.
Gozdowska
M
M
Kołodziejczyk
A M
AM
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002626:Chemistry, Pharmaceutical; D016207:Cytokines / Q000494:pharmacology; D004357:Drug Synergism; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D004731:Endotoxins / Q000494:pharmacology; D006801:Humans; D007239:Infections / Q000628:therapy*; D009112:Muramic Acids / Q000008:administration & dosage*; D010272:Parasitic Diseases / Q000188:drug therapy*; D014405:Tuftsin / Q000494:pharmacology; D014612:Vaccines / Q000737:chemistry
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D016207:Cytokines; D004731:Endotoxins; D009112:Muramic Acids; D014612:Vaccines; D014405:Tuftsin